) is a cytokine that preferentially effects the development and function of eosinophils, and is considered important in the pathophysiology of allergic inflammation. In this study, we evaluated the ability of recombinant human IL-5 (rHu IL-5) to promote tissue eosinophilia and the importance of this eosinophilia to pathological alterations in vascular function. Repetitive subcutaneous administration for 18 days of rHu IL-5 resulted in a 7-fold increase in the number of eosinophils found in the ipsilateral hamster cheek pouch membrane. The contralateral cheek pouch membrane and peritoneum of these animals showed lesser but significant elevations in the number of eosinophils. In contrast, denatured rHu IL-5 did not elevate eosinophils in these tissues. Through the use of intravital microscopy and fluorometric analysis, rHu IL-5 treated hamster cheek pouch membranes were evaluated for alterations in microvascular permeability, using plasma clearance of FITC-dextran 150 as an index. Despite promoting a prominent tissue eosinophilia, the repetitive subcutaneous injections of rHu IL-5 did not alter the clearance of FITCdextran 150. Topical application of rHu IL-5 to the cheek pouch, also, had no effect on the clearance of FITC-dextran 150. Immunofluorescence observations using an antibody to the granule protein, eosinophil peroxidase, indicated that the recruited cells had not degranulated. Our results support the importance of IL-5 in the recruitment of tissue eosinophils, but further stimulation is probably required to cause degranulation of these cells and the ensuing tissue damage.
Introduction
Elevated numbers of eosinophils in the blood and tissues is a common feature associated with allergic reactions. [1] [2] [3] Through the generation of inflammatory lipid mediators, like platelet activating factor (PAF) or leukotrienes, and the release of biologically active granule proteins, the eosinophil leukocyte has been documented as a potent effector cell capable of contributing to the pathophysiology of allergic disorders.4-C-In support of this hypothesis, we and others have shown that eosinophil granule proteins can cause increased vascular macromolecular permeability, which may lead to oedema. 7'a Cytokines such as granulocyte-macrophage colony stimulating factor (GM-CSF) and the interleukins (IL) 3 '12 Furthermore, IL-5 affects the activation, chemotatic responses, degranulation, and decreased apoptosis of per- [13] [14] [15] ipheral blood derived eosinophils.
Because IL-5 possesses biological activity across species, we used recombinant human IL-5 to induce eosinophilia in the Syrian hamster. '7 In order to investigate whether cytokine-induced tissue eosinophilia promotes oedema, we used the plasma clearance of fluoroscein isothiocyanate (FITC)-dextran 150 in the hamster cheek pouch preparation as a measure of changes in vascular permeability.
Materials and Methods
The male golden Syrian hamsters (80-100g) used for these experiments were cared for in accordance with the guidelines of the Animal (C) 2 Prepara-viously. '2 After surgical preparation, the hamster tion and analysis were performed without prior was positioned on a lucite board mounted on knowledge of the treatment applied, the stage of a Nikon Optiphot microscope. A 1 h To obtain peritoneal eosinophils, the perito-stabilization period followed the surgery, during neum was lavaged with 10ml of normal saline which the pouch was continuously suffused with and the accompanying cells were recovered using bicarbonate buffer (1 ml/min; 37C). (0.01 mg) to the right cheek showed a substantial (Fig. 3a,b,c) . Cells reactive with anti-EPO were increase in the number of eosinophils in the visible as discrete fluorescent ovals.
ipsilateral pouch membrane (Fig. 1) . A statistiRepetitive subcutaneous injections of rHu IL-5 cally significant rise in the number of membrane to the cheek pouch of hamsters resulted in a eosinophils occurred by the second day. Sub-marked increase in the percentage of recoverable sequent injections of rHu IL-5 further increased peritoneal eosinophils (Fig. 4) . Rising from initial the number of eosinophils and, by day 18, a 7-values of 12 + 2.3%, the percentage of peritoneal fold increase in the number of eosinophils was eosinophils increased to 21 + 0.9% after 9 days seen in treated membranes (Fig. 1) (Fig. 4) .
phil bone marrow production, release, directed migration and activation. The need for IL-5 bioactivity to cause the eosinophilia was confirmed by treating with denatured rHu IL-5 and failing to find a similar pattern of eosinophilia, both locally and systemically. Nevertheless, at the site of injection, within the underlying membrane, a small but detectable increase in the number of eosinophils was noted. Because no effect was detected in the contralateral membrane or in the peritoneal cell differential, we believe that this small local increase in eosinophils is probably due to the repetitive injections of a foreign denatured protein. The possibility that repetitive needle punctures (27 gauge) may have resulted in a fibrotic wound healing condition, causing the recruitment of eosinophils cannot be excluded. 39 However, we believe this to be an unlikely explanation for our observations. In the wound healing models of tissue eosinophilia, the cutaneous wounds are substantially larger than that provoked by our 39 40 needle punctures.
Furthermore, in our model we are studying the underlying oral membrane after the removal of the overlying, loose connective aerolar tissue.
The capacity of IL-5 to direct selective eosinophil chemotaxis has been reported from in vitro 41 42 studies.
Recent experiments also suggest that local production of IL-5 is responsible for eosinophil recruitment after antigen challenge in allergic individuals. 4 The cellular signaling for eosinophil chemotaxis is through the binding of IL-5 to specific surface receptors on the mature eosinophil leukocyte. 44 45 However, it is in contrast with the observations of eosinophilia and IL-5 in the IL-2 induced capillary leak syndrome. 35 Because the hamster cheek pouch membrane microcirculation offers an accessible vascular network that has been intensely studied and responds to eosinophil granule proteins, it may be useful for establishing the parameters needed to elicit tissue damage by enhanced eosinophil degranulation.
